Tag: Representative Rosa DeLauro
Volume 395 Number 10222 8 February 2020 Prospects for health after the US mid-terms
Volume 392, Number 10161
24 November 2018
WORLD REPORT After the mid-term elections, Susan Jaffe, The Lancet‘s Washington correspondent, looks at the consequences for health-care legislation in the USA.
In the first national election since Donald Trump won the presidency promising, among other things, to repeal the Affordable Care Act (ACA), Americans went to the polls this month still concerned about health care. It was the most important issue for 75% of Democrats and 23% of Republicans who voted in the Nov 6 elections, according to exit polls. But, unlike in 2016, voters handed Democrats—the party responsible for the ACA—their largest victory since Republican Richard Nixon resigned as president after the Watergate scandal….
“Health care was on the ballot and health care won”, said the House of Representatives’ Democratic minority leader Nancy Pelosi of California, who is expected to become speaker of the house when the new Congress convenes in January. [Continued here.]
… US Children’s Health Insurance Program in jeopardy
Volume 390, Number 10114
23/30 December 2017
WORLD REPORT Without adequate federal funding, CHIP is on the verge of collapse in several states. Susan Jaffe, The Lancet’s Washington correspondent, reports.
“Whoever would have thought that health care for children—that has support on both sides of the aisle—would be in this situation?” asked Deborah Oswalt, executive director of the Virginia Health Care Foundation. [full story here]
…
High stakes for research in US 2018 budget negotiations
Volume 390, Number 10099
9 September 2017
WORLD REPORT As Congress considers how to fund the government next year, scientists hope spending for research will not be curtailed. Susan Jaffe, The Lancet’s Washington correspondent, reports.
The dramatic defeat of the Republicans’ Affordable Care Act (ACA) repeal legislation still looms over the US Capitol as Congress reconvenes this month for more tough decisions, including many that will affect health and science research programmes. …The prospects for science funding will depend on competing budget pressures and political fissures. “There are a lot of moving parts and a lot of uncertainty”, said Matt Hourihan, at the American Association for the Advancement of Science. “And while a spending deal [agreement] is certainly possible, it’s hard to see how they get there from here.” [Continued here]…